Want to see AU:EVE full AI Analyst Report?
EVE Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.04
Previous CloseN/A
Volume9.81K
Average Volume (3M)774.07K
Market Cap
AU$5.99M
Enterprise ValueAU$3.85M
Total Cash (Recent Filing)AU$929.66K
Total Debt (Recent Filing)AU$38.51K
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding352,326,600
10 Day Avg. Volume491,958
30 Day Avg. Volume774,070
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.22
Price to Sales (P/S)2.49
P/FCF Ratio-2.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low LeverageVery low leverage (debt-to-equity ~0.03) provides durable financial flexibility, lowering solvency and interest risks. Over a 2-6 month horizon this balance-sheet conservatism supports funding operations or strategic actions without heavy borrowing while profitability is being addressed.
Free Cash Flow ImprovementImproving free cash flow and a stable FCF-to-net-income ratio indicate progress in cash generation despite losses. Sustained FCF improvement reduces reliance on external financing, supports working capital needs and selective reinvestment, and materially improves survivability over the medium term.
Gross Margin ImprovementRising gross profit margins suggest better product mix, pricing power or COGS control. If sustained, improved gross margins create structural room to absorb fixed operating costs and are a necessary step toward restoring operating profitability and long-term margin sustainability.
Bears Say
Declining RevenueA notable revenue decline (~13.4%) reduces scale and undermines unit economics. Continued top-line contraction limits ability to leverage fixed costs, compresses margins, and raises the break-even requirement, making recovery dependent on reversing demand trends or finding new revenue streams.
Persistent LossesOngoing negative net profit and operating margins show the core business currently lacks economic viability. Persistent losses erode equity, constrain reinvestment in distribution or product development, and hinder the firm's capacity to compete and reach sustainable profitability over the medium term.
Negative Operating Cash FlowNegative operating cash flow and poor cash conversion signal the business cannot reliably generate cash from operations. This forces dependence on financing or shareholder support, restricts day-to-day flexibility and raises liquidity and refinancing risks in the coming months.
EVE Health Group Limited News
EVE FAQ
What was EVE Health Group Limited’s price range in the past 12 months?
EVE Health Group Limited lowest share price was AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is EVE Health Group Limited’s market cap?
EVE Health Group Limited’s market cap is AU$5.99M.
When is EVE Health Group Limited’s upcoming earnings report date?
EVE Health Group Limited’s upcoming earnings report date is Sep 02, 2026 which is in 48 days.
How were EVE Health Group Limited’s earnings last quarter?
EVE Health Group Limited released its earnings results on Feb 27, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is EVE Health Group Limited overvalued?
According to Wall Street analysts EVE Health Group Limited’s price is currently Overvalued.
Does EVE Health Group Limited pay dividends?
EVE Health Group Limited does not currently pay dividends.
What is EVE Health Group Limited’s EPS estimate?
EVE Health Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EVE Health Group Limited have?
EVE Health Group Limited has 352,326,600 shares outstanding.
What happened to EVE Health Group Limited’s price movement after its last earnings report?
EVE Health Group Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of EVE Health Group Limited?
Currently, no hedge funds are holding shares in AU:EVE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EVE Health Group Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:EVE Sentiment 100%
Sector Average 63%
Sector Average 63%
Insider Transactions
Bought Shares
Worth AU$10.0K over
the Last 3 Months
the Last 3 Months
Fundamentals
Return on Equity
-44.35%
Trailing 12-Months
Asset Growth
348.70%
Trailing 12-Months
Company Description
EVE Health Group Limited
Based in Subiaco, Australia, Eve Health Group Limited, originally incorporated in 2003 as EVE Investments Limited, is an international provider of health, wellness, and nutritional products. The company operates across Australia, New Zealand, the Asia Pacific region, and North America. Its activities include the production of organic tea tree oils, the distribution of botanical oils, and the supply of a wide array of other oils such as essential oils, hydrosols, extracts, carrier oils, and seed oils. Furthermore, Eve Health Group offers organic raw honey and raw honey probiotic concentrates, alongside contract manufacturing services. A key area of its focus is developing medical nutrition solutions for chronic and lifestyle ailments, exemplified by Gluco Smooth, a product designed to help manage type 2 diabetes by moderating post-meal blood sugar levels, as well as providing various dietary intervention programs.
Technical Analysis
Australian Dairy Nutritionals Group
―
―
Nuchev Pty Ltd
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―